The new rules close the loopholes that enabled Dr He to evade regulations, which previously only applied to experiments on…
BIRMINGHAM, Ala. – Meier-Gorlin syndrome, or MGS, is a rare genetic developmental disorder that causes dwarfism, small ears, a small brain, missing patella and other skeletal abnormalities. In severe cases, MGS results in miscarriages and stillbirths.
Igor Chesnokov, Ph.D., and his University of Alabama at Birmingham colleagues study this recessive, autosomal disorder in an unusual way — by placing mutant human genes into fruit flies. Specifically, they look at one of the genes involved in MGS called Orc6.
In a study published in Genetics, featured as a highlighted article, they used this animal model to probe the function of one human Orc6 mutation — a Lysine 23 to Glutamic acid (K23E) substitution — that was first reported in 2017. In people with MGS, the K23E mutation causes a similar observable developmental disorder as an Orc6 mutation that the Chesnokov team previously studied, Tyrosine 225 to Serine (Y225S) substitution.
Those two mutations are interesting to contrast, because position 23 is near the front, or the N-terminal domain, of the long chain of connected amino acids that folds to form the Orc6 protein. Position 225 is near the end, or the C-terminal domain, of the Orc6 protein strand.
Orc6 is part of the Origin Recognition Complex, or ORC. This complex of proteins is vital to initiate DNA replication in a cell, whether yeast, fruit fly, human or any other eukaryotic organism. Without DNA division, a cell cannot divide and an organism cannot grow. Poor division will stunt growth, as is seen in MGS.
In previous research on the Y225S mutation, published in the American Journal of Medical Genetics, the UAB researchers found that the C-terminal domain of Orc6 is important for protein-protein interactions to help build the ORC complex. In the current study, Chesnokov and colleagues have now found that the K23E mutation in the N-terminal domain of Orc6 disrupts the protein’s ability to bind to DNA. This specific binding is a vital step in ORC function.
Thus, although the two mutations have different underlying molecular mechanisms, they both cause deficient pre-replicative complex formation and reduced DNA replication, and they produce a similar phenotype in MGS patients.
One key in this research was creating chimeric Orc6 genes that are part human gene and part fruit fly gene. Here is why that was necessary. Putting a human Orc6 gene into fruit flies fails to prevent the lethal effect of an Orc6 deletion in fruit flies; in other words, the intact human Orc6 cannot replace the function of the fruit fly Orc6, due to the difference in Orc6 interactions with the core ORC in the two organisms.
However, when the UAB researchers made a hybrid Orc6 that was human in the N-terminal domain and fruit fly in the C-terminal domain, the hybrid was able to completely rescue the fruit flies, and they grew into adults that were undistinguishable from fruit flies with wild-type Orc6. This hybrid Orc6 then could be used to test the K23E mutation in fruit flies and study its molecular mechanism.
“This hybrid approach,” Chesnokov said, “allows the study of human protein functions in an animal system, and it revealed the importance of evolutionary conserved and variable domains of the Orc6 protein. We believe that this hybrid approach not only opens a broad avenue to study new Orc6 mutations for medical and general science purposes, but also might be useful in other humanized models.”
In summary, says Chesnokov, a professor in the UAB Department of Biochemistry and Molecular Genetics, this humanized fly model has the unique advantage of being able to differentially test fly, human, and chimeric Orc6 proteins to reveal conserved and divergent features of the protein and its function in the cells of metazoan organisms.
Co-authors with Chesnokov of the study, “Humanized drosophila model of the Meier-Gorlin Syndrome reveals conserved and divergent features of the Orc6 protein,” are Maxim Balasov and Katarina Akhmetova, UAB Department of Biochemistry and Molecular Genetics.
Support came from National Institute of General Medical Sciences grant GM121449.
In related news, UAB this fall received a $9.3 million grant from the National Institutes of Health’s Office of Research Infrastructure Programs to create a new Center for Precision Animal Modeling, or C-PAM.
The work of the Chesnokov team is an example of precision disease modeling, which involves creation of patient-specific disease models — often using yeast, worms, fruit flies, zebrafish, frogs, mice or rats. Chesnokov says that adding a Drosophila Core to the disease modeling unit of C-PAM could consolidate UAB fly labs and provide necessary expertise for the UAB community.
Precision animal models mimic the molecular character of a condition present in a patient. For example, if a patient has a disease caused by a sequence variant leading to the dysfunction of a gene, then C-PAM will create an animal model with this same variant. Studying the effect that the variant has in the model makes it possible to do science that is not possible in the human patient.